Use caution Drug recall · FDA · Published May 19, 2020

LidoPro Patch Recall: CGMP Deviations Risk

Terrain Pharmaceuticals recalls LidoPro patches due to CGMP deviations. No assurance product stays within spec through expiration date.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-1278-2020Drug LidoPro ›

Use caution until it’s fixed

CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the labeled expiration date.

Take action

Contact the company

Recalling firmWuhan Bingbing Pharmaceutical Co., Ltd.Building, F, No.5, Kangda Street · Wuhan, China

✎ GovInfoNow plain-language explainer

Terrain Pharmaceuticals is recalling LidoPro (lidocaine 4%, menthol 5%, methyl salicylate 4%) patches because of Current Good Manufacturing Practice (CGMP) deviations. The manufacturer lost product manufacturing records and retain samples, meaning there is no assurance the product will remain within specification through its labeled expiration date. This recall affects 54,000 boxes distributed nationwide in the USA. Read more at govinfonow.com/recall/37110-lidopro-patch-recall-cgmp-deviations-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/37110-lidopro-patch-recall-cgmp-deviations-risk · Updated October 11, 2026 · FDA enforcement record: FDA #D-1278-2020

Cite this page

“LidoPro Patch Recall: CGMP Deviations Risk.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/37110-lidopro-patch-recall-cgmp-deviations-risk. Based on FDA recall #D-1278-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1278-2020%22&limit=1).

The FDA announced on May 19, 2020, that Wuhan Bingbing Pharmaceutical Co., Ltd. is recalling LidoPro pain relief patches due to current good manufacturing practice deviations. The company initiated the voluntary recall after losing product manufacturing records and retain samples.

How to tell if you have it

Brand: LidoPro
Product: LidoPro Pain Relief Patches (lidocaine 4%, menthol 5%, methyl salicylate 4%)
NDC: 53225-1023-1
Batch #: 170527
Expiration Date: 2020.05
Quantity: 54,000 boxes

The hazard

Due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the labeled expiration date. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show other recent recalls of similar products include Wells Pharma Fentanyl Citrate Injectable Solution Recall (2026-04-01) and Pro N: 5% Lidocaine Tattoo Numbing Spray Recall (2026-02-02). Another related recall was the Wells Pharma Fentanyl Citrate Recall reported on 2026-04-01.

How to tell if you have this one

Check your box for the brand name LidoPro, manufactured by Wuhan Bingbing Pharmaceutical Co., Ltd. and sold by Terrain Pharmaceuticals. Look for NDC 53225-1023-1 and Batch # 170527 with an expiration date of May 2020 (Exp 2020.05). The box contains 15 patches.

Brand
LidoPro
Category
Drug

FDA recall event · 4 products

All 4 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

Classification
Class II
Status
Ongoing
Distribution
Nationwide in the USA

Recall number	Product, codes & lots	Quantity
D-1277-2020	LidoPatch (lidocaine HCl 3.6%, menthol 1.25%) Pain Relief Patch, packaged in 1 patch/box (NDC 10882-527-01); 30 patches/box (NDC 10882-527-02 and 10882-527-04), Manufactured for: JAR Laboratories, Elmhurst, IL.; Batch #: 1180103, Exp 2021.01.02; 180104, Exp 2021.01.03; 80105, Exp 2021.01.04; 180106, Exp 2021.01.05; 80107, Exp 2021.01.06.	4,960 boxes
D-1278-2020	LidoPro (lidocaine 4%, menthol 5%, methyl salicylate 4%) patch, 15 Patches per box, Manufactured For: Terrain Pharmaceuticals, Reno, NV 89501; NDC 53225-1023-1.; Batch #: 170527, Exp 2020.05	54,000 boxes
D-1279-2020	Mencaine (lidocaine 4.5%, menthol 5%) Patch, 1 patch per pouch, Manufactured For: Terrain Pharmaceuticals, Reno, NV 89501; NDC 53225-1090-1.; Batch #: 170731, Exp 2020.07; 180504; Exp 2021.05	1,800 pouches
D-1280-2020	Maximum Strength Lidocaine Cold & Hot Patch (lidocaine 4%, menthol 1%), 5 patches per box, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895; NDC 66902-218-05.; Batch #: 170614, Exp 2020.06.13; 180108, Exp 2021.01.07; 180109, Exp 2021.01.08; 180110, Exp 2021.01.09; 180111, Exp 2021.01.10, 180112, Exp 2021.01.11; 180113, Exp 2021.01.12; 180317, Exp 2021.03.16; 180318, Exp 2021.03.17	72,600 boxes

Based on the official FDA remedy

What to do — step by step

Check your product details
Verify if you have LidoPro patches with NDC 53225-1023-1 and Batch # 170527 expiring in May 2020.
Contact the manufacturer
Reach out to Terrain Pharmaceuticals for further instructions, as no specific remedy or return process is currently stated in the record.

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 15 days after the firm started it.

May 19, 2020Firm started the recall
May 28, 2020FDA classified it Class II
Jun 3, 2020Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/37110-lidopro-patch-recall-cgmp-deviations-risk">LidoPro Patch Recall: CGMP Deviations Risk (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-1278-2020 (May 19, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1278-2020 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.